Developing Resiliency and Exercise Using AI-based Messaging

Part of paid clinical trials in Boston, Massachusetts.

Sponsor
Massachusetts General Hospital
Study ID
NCT07225283
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Diabetes Mellitus Type 2

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

  • DREAM — BEHAVIORAL
    Participants will engage in twice weekly messaging sessions and will work towards a physical activity goal each week for a total of eight weeks.

Study Details

This is a randomized, controlled pilot trial to examine the feasibility, acceptability, and preliminary efficacy of the DREAM program, an 8-week message-based intervention to promote physical activity and well-being in adults with type 2 diabetes.

Key Dates

Start date
Sep 1, 2026
Status verified
May 2026
Primary completion
Mar 31, 2027
Completion
Mar 31, 2027

Study Design

Enrollment
20 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION

Arms

  • Experimental: DREAM
    Participants will engage in twice weekly, interactive messaging sessions with DREAM, a computer-based messaging system designed to help people engage in more physical activity and improve overall well-being. In the first session of each week, participants will set a physical activity goal and learn a new positive psychology topic. They will review goals and topics from the prior week. In the second session, participants will be reminded of the goals set during the first messaging session earlier that week. The program will run for eight weeks.
  • No Intervention: Wait-list control
    Participants in the wait-list control condition will engage in usual medical care for eight weeks, then will complete the DREAM program.

Primary Outcome Measure

Delivery of messaging sessions (feasibility) [ Time Frame: Twice weekly over 8 weeks ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Massachusetts General HospitalBostonMassachusetts02114
Christopher M Celano, M.D.
[email protected]
617-726-6485

Find similar trials in Boston, MA

By research site
Massachusetts General Hospital· Boston, MA

Related Studies